Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 1, 2005, Pages 73-79

  Kim, Kenneth T ^a   Kerwin, Edward ^b   Landwehr, Lawrence ^c   Bernstein, Jonathan A ^d   Bruner, Dawn ^a   Harris, Duane ^e   Drda, Kristin ^f   Wanger, Jack ^g   Wood, Chester C ^f  

^a West Coast Clinical Trials LLC   (United States)

^b Clinical Research Institute of Southern Oregon PC   (United States)

^c Clinical Research of the Ozarks Inc   (United States)

^d Bernstein Clinical Research Center   (United States)

^e Intermountain Clinical Research   (United States)

^f BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^g PRA HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTITUSSIVE AGENT; EYE DROPS; IPRATROPIUM BROMIDE; NAPHAZOLINE;

ALLERGY; ANTICHOLINERGIC EFFECT; ARTICLE; COMMON COLD; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RHINORRHEA; SCORING SYSTEM; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 12344288231     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61289-6     Document Type: Article

References (16)

1. National Center for Health Statistics. Current Estimates From the National Health Interview Survey, United States, 1990. Washington, DC: Public Health Service; 1991.
2. Broder I, Higgins MW, Matthews RP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community: Tecumseh, Michigan. J Allergy Clin Immunol. 1974;53:127-138.
3. Schlumberger HD. Epidemiology of allergic diseases. In: Dukor P, editor. Monograms in Allergy. Vol 21. Basel, Switzerland: Karger; 1987:1-288.
4. Druce H, Spector S, Fireman P, et al. Double-blind trial of intranasal ipratropium bromide in non-allergic perennial rhinitis. Ann Allergy Asthma Immunol. 1992;69:53-60.
5. Meltzer EO, Orgel HA, Bronsky E, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a trial of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol. 1992;90:242-249.
6. Spector S. Intranasal anticholinergic treatment of nasal disorders. J Allergy Clin Immunol. 1992;90:1041-1086.
7. Milgrom H, Biondi R, Georgitis JW, et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol. 1999;83:105-111.
8. Dockhorn R, Aaronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999;82:349-359.
9. Physicians Desk Reference. 58th ed. Montvale, NJ: Thomson PDR; 2004:997-1000.
10. Dockhorn R, Grossman J, Posner M, Zinny M, Tinkleman D. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. J Allergy Clin Immunol. 1992; 90:1076-1082.
11. Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995;95:1117-1122.
12. Kaiser HB, Findlay SR, Georgitis JW, et al. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. J Allergy Clin Immunol. 1995;95:1128-1132.
13. Diamond L, Dockhorn RJ, Grossman J, et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol. 1995;95:1139-1146.
14. Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996;125:89-97.
15. Meltzer EO, Orgel HA, Biondi R, et al. Ipratropium nasal spray in children with perennial rhinitis. Ann Allergy Asthma Immunol. 1997;78:485-491.
16. Kaiser HB, Findlay SR, Georgitis JW, et al. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Allergy Asthma Proc. 1998;19:23-29.